Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 175

The DOI matches its Crossref record.

Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors

Open access
MacLennan, S J, Reynen, P H, Kwan, J, Bonhaus, D W·1998·British Journal of Pharmacology

Abstract

The cannabinoid receptor antagonist SR141716A has been suggested to be an inverse agonist at CB 1 receptors in some isolated intact tissues. We found that the basal incorporation of [35 S]‐GTPγS in Chinese hamster ovary cells expressing human recombinant CB 1 and CB 2 receptors was inhibited by SR141716A (mean pEC 50 s 8.26 and 6.00, respectively), whereas cannabinol (10 μ M) had no significant effect at hCB 1 receptors but inhibited the binding at hCB 2 receptors. As cannabinol had no effect on basal [35 S]‐GTPγS binding at hCB 1 at a concentration 100 fold higher than its binding affinity (Ki=0.1 μ M), we conclude that endogenous cannabinoid receptor agonists are not a confounding factor and suggest the actions of SR141716A at the hCB 1 receptor, and the actions of SR141716A and cannabinol at the hCB 2 receptor, are due to inverse agonism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0701915

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 175

Metadata

Authors
MacLennan, S. J., Reynen, P. H., Kwan, J., & Bonhaus, D. W.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1998-06
Volume
124
Issue
4
Pages
619-622
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2015708394
Cited by
175
References
0
FWCI
11.82
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors. https://app.cochat.ai/papers/10.1038/sj.bjp.0701915
The paper
MacLennan, S. J., Reynen, P. H., Kwan, J., & Bonhaus, D. W. (1998). Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0701915

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.